1.48BMarket Cap
LossP/E TTM
Novavax Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Novavax Inc is 9.19, ranking 49 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -16.29, which is -129.04% below the recent high of 4.73 and -21.47% above the recent low of -19.79.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.